Stock listing
Biodlink International Company Limited
Selected listing: 1875 · HKEX · HKD · HK
Biodlink International Company Limited (HKEX:1875), Health Technology. Latest release Sep 29, 2026: INTERIM REPORT 2026.
- Ticker
- HKEX:1875
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- HKEX
- Currency
- HKD
About Biodlink International Company Limited
The company focuses on innovative solutions in its sector, aiming to enhance its market presence and operational efficiency. Investors can find more information about its activities and performance on its public company page.
Latest news from Biodlink International Company Limited
INTERIM REPORT 2026
September 29, 2026
BioDlink Named "Emerging CDMO of the Year" at the 2026 Asia-Pacific Biopharma Excellence Awards
March 13, 2026
BioDlink Recognized by Client for Enabling the World's First Dual-Payload ADC to Enter Clinical Trials
February 9, 2026
BioDlink Showcases Europe-China CMC Collaboration Amid Developmental Breakthrough
November 28, 2025
BioDlink and Lepu Biopharma Celebrate Successful Launch of the World's First EGFR-Targeting ADC Drug, Marking a Major Milestone in Mutual Collaboration in Biologics CMC
November 21, 2025
Research Biodlink International Company Limited
Biodlink International Company Limited company profile
View the public company page for Biodlink International Company Limited on 6ix.
Biodlink International Company Limited news
Read company news and market updates connected to Biodlink International Company Limited.
Biodlink International Company Limited investor events
Find investor webinars, events, and replay context for Biodlink International Company Limited.